Case Discussions in Interventional Glaucoma: Best Practices for Using Implants and MIGS (CME Symposium)
To claim your credit, please click Register/Take Course.
Monday, October 21, 2024
6:00 AM – 6:30 AM CT Registration and Breakfast
6:30 AM – 8:00 AM CT CME Symposium and Virtual Broadcast
InterContinental Chicago Magnificent Mile
Renaissance Ballroom, 5th Floor
505 North Michigan Avenue
Chicago, Illinois
Target Audience
This educational activity is intended for ophthalmologists.
Learning Objectives
After completing this activity, participants will be better able to:
- Demonstrate use of glaucoma sustained-release drug delivery devices for managing intraocular pressure in patient scenarios
- Select appropriate minimally invasive glaucoma surgical devices to manage intraocular pressure in patient scenarios
- Describe procedural techniques for minimally invasive glaucoma surgical procedures that improve patient outcomes
Faculty
Joseph F. Panarelli, MD (Chair) | |
Eileen C. Bowden, MD Assistant Professor of Ophthalmology Associate Residency Program Director Dell Medical School University of Texas at Austin Austin, Texas | |
Arsham Sheybani, MD |
Disclosure Policy
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Faculty
Eileen C. Bowden, MD, is an advisory board member of AbbVie Inc*.
Joseph F. Panarelli, MD, is a consultant for AbbVie Inc, Advanced Ophthalmic Innovations Pte Ltd, Alcon, CorneaGen, CorNeat Vision, Glaukos Corporation, New World Medical, Inc, Nova Eye Medical, Santen Inc, and Zeiss.
Arsham Sheybani, MD, is a consultant for AbbVie Inc, Alcon, Glaukos Corporation, and Nova Eye Medical.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners and managers have no relevant commercial relationships to disclose.
* The financial relationship existed during the past 24 months but has now ended
Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from AbbVie Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or AbbVie Inc.
This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 333.1
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation